Insider Shareholders with Direct Ownership of Immunity Bio, Inc. (IBRX)
This section provides a comprehensive overview of the insiders with direct ownership of Immunity Bio, Inc. (IBRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ImmunityBio, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Patrick Soon Shiong
Director |
5,837,511 | 42,071 | 29,546,190 $89.5 Million | 3 |
Feb 22, 2025
Reduced 0.14%
|
Barry J. Simon
Director |
578,729 | 434,647 | 3,243,571 $9.83 Million | 20 |
Feb 22, 2025
Reduced 0.17%
|
Richard Adcock
CEO & President |
638,645 | 304,227 | 334,418 $1.01 Million | 18 |
Feb 22, 2025
Reduced 18.95%
|
David C. Sachs
Chief Financial Officer |
275,371 | 68,611 | 225,620 $683,628 | 12 |
Feb 22, 2025
Reduced 6.57%
|
John C Thomas
Director |
0 | 42,592 | 207,477 $628,655 | 1 |
Dec 10, 2020
Reduced 17.03%
|
Cheryl Cohen
Director |
0 | 70,308 | 200,617 $607,869 | 4 |
Aug 23, 2021
Reduced 6.87%
|
Regan J Lauer
Chief Accounting Officer |
132,900 | 22,642 | 110,258 $334,081 | 9 |
Feb 22, 2025
Reduced 1.49%
|
John Owen Brennan
Director |
25,000 | 0 | 25,000 $75,750 | 1 |
Jun 02, 2023
Added 28.57%
|
Sonja Nelson
Chief Financial Officer |
34,093 | 55,635 | 15,410 $46,692 | 4 |
Jan 12, 2021
Reduced 51.5%
|
Wesley Clark
Director |
7,000 | 0 | 8,000 $24,240 | 1 |
Jun 01, 2023
Added 46.67%
|